| 000 | 01782 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513183530.0 | ||
| 264 | 0 | _c19990701 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.274.23.16047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiethmüller, C | |
| 245 | 0 | 0 |
_aActivation of neuronal nitric-oxide synthase by the 5-methyl analog of tetrahydrobiopterin. Functional evidence against reductive oxygen activation by the pterin cofactor. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJun 1999 |
||
| 300 |
_a16047-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aBiopterins _xanalogs & derivatives |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xenzymology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type I |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aOxygen _xmetabolism |
| 650 | 0 | 4 | _aOxygen Consumption |
| 650 | 0 | 4 |
_aPterins _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSpodoptera |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 700 | 1 | _aGorren, A C | |
| 700 | 1 | _aPitters, E | |
| 700 | 1 | _aHemmens, B | |
| 700 | 1 | _aHabisch, H J | |
| 700 | 1 | _aHeales, S J | |
| 700 | 1 | _aSchmidt, K | |
| 700 | 1 | _aWerner, E R | |
| 700 | 1 | _aMayer, B | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 274 _gno. 23 _gp. 16047-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.274.23.16047 _zAvailable from publisher's website |
| 999 |
_c10305838 _d10305838 |
||